Comorbid status of patients with chronic obstructive pulmonary disease
Abstract
Aim: to study the frequency of occurrence of comorbid pathology in hospitalized patients with chronic obstructive pulmonary disease (COPD). Material and methods. We conducted a retrospective analysis of 688 “inpatient medical records” of patients undergoing treatment from September 2016 to February 2017 in City Hospital No.5 of Nizhny Novgorod, of which 142 (20.6%) patients were diagnosed with COPD. As the main disease, COPD was found in 79.6% of cases, and as a concomitant disease in 20.4% of cases. Of 142 cases, the majority of patients were men – 58.5% (83 patients), whose mean age was 67.8±12.4 years and who had a long history of smoking. 41.5% (59 patients) were women, whose mean age was 73.9±11.8 years.
About the Authors
N. Yu. Grigoryeva
City clinical hospital № 5
Russian Federation
Russian Federation
M. E. Korolyova
Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University»
Russian Federation
Russian Federation
E. M. Yashina
Federal State Budgetary Educational Institution of Higher Education «Privolzhsky Research Medical University»
Russian Federation
Russian Federation
References
1. Chazova I.E., Lazareva N.V., Oshchepkova E.V. Arterial’naya gipertoniya i hronicheskaya obstruktivnayaтbolezn’ legkih: klinicheskaya harakteristika i effektivnost’ lecheniya (po dannym Nacional’nogo registra arterial’noj gipertonii) [Arterial hypertension and chronic ob-structive pulmonary disease: clinical characteristics and treatment efficacy (according to the na-tional register of arterial hypertension)]. Terapevticheskij arhiv, 2019, no. 3, pp. 4-10. (in Rusian).
2. Mannino D.M., Higuchi K., Yu T.C. Economic burden of COPD in the presence of comorbidities. Chest, 2015, vol. 148, no. 1, pp. 138-150.
3. Diagnostika i lechenie pacientov s hronicheskoj obstruktivnoj bolezn’yu legkih i arte-rial’noj gipertenziej [electronic resource]: nacional’nye klinicheskie rekomendacii Minzdrav RF; RNMOT [Diagnosis and treatment of patients with chronic obstructive lung disease and ar terial hyper tension: national clinical guidelines recommendations]. M., 2017. 76 s. Available at: https://www.armos. com/public/uploads/RNMOT/clinical/2017/HOBL%20i%20AG%20Malyavin_250618.pdf. (accessed: 09.03.2018). (in Russian).
4. Smiljic S., Radović D., Nestorović V., Milanović Z. Endothelins as mediators in the modulation of cardiac performance. Praxis Med, 2014, vol. 3, no. 4, pp. 79-84.
5. Carev V.P., Sushkevich A.V. Hronicheskaya obstruktivnaya bolezn’ legkih i pul’mogennaya arterial’naya gipertenziya [Chronic obstructive pulmonary disease and pulmogenic arterial hypertension]. Medicinskij zhurnal, 2017, no. 2, pp. 52-58. (in Russian).
6. Charlson M.E., Sax F.L. The therapeutic efficacy of critical care units from two perspectives: a traditional cohort approach vs a new case-control methodology. J Chronic Dis, 1987, vol. 40, suppl 1, pp. 31-39.
7. Kravchenko A.Ya., Bogdanova T.G. Osobennosti ar terial’noj giper tenzii u zhenshchin detorodnogo vozrasta [Peculiarities of arterial hypertension in fertile women]. Problemy zhenskogo zdorov’ya, 2011, vol. 6, no. 2, pp. 71-73. (in Russian).
Review
For citations:
Grigoryeva N.Yu., Korolyova M.E., Yashina E.M. Comorbid status of patients with chronic obstructive pulmonary disease. Emergency Cardiology and Cardiovascular Risks journal. 2020;4(1):824–829. (In Russ.) https://doi.org/616.24-036.12
Views:
24
Email this article 